1. Home
  2. LION vs SYRE Comparison

LION vs SYRE Comparison

Compare LION & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lionsgate Studios Corp.

LION

Lionsgate Studios Corp.

HOLD

Current Price

$8.09

Market Cap

2.4B

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$37.07

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LION
SYRE
Founded
1997
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.6B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
LION
SYRE
Price
$8.09
$37.07
Analyst Decision
Buy
Strong Buy
Analyst Count
9
6
Target Price
$10.06
$56.50
AVG Volume (30 Days)
2.5M
584.9K
Earning Date
02-05-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,954,100,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$22.98
N/A
P/E Ratio
N/A
N/A
Revenue Growth
39.38
N/A
52 Week Low
$5.55
$10.91
52 Week High
$10.09
$37.98

Technical Indicators

Market Signals
Indicator
LION
SYRE
Relative Strength Index (RSI) 35.63 64.27
Support Level $7.95 $32.35
Resistance Level $9.59 $35.58
Average True Range (ATR) 0.46 1.90
MACD -0.17 0.22
Stochastic Oscillator 7.69 80.88

Price Performance

Historical Comparison
LION
SYRE

About LION Lionsgate Studios Corp.

Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: